ENLV Competitors & Alternatives
Compare Enlivex Therapeutics Ltd with similar stocks in the same industry
Biotechnology
ENLV
Main Stock$4.26
Tradestie Score
51
Market Cap
$25.02M
P/E Ratio
0.0
Analyst Upside
+6942.3%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.54
|
$154.27M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.79
|
$133.50M | - | 55 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.04
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.87
|
$110.20M | - | 57 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.92
|
$84.52M | - | 40 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.20
|
$71.69M | - | 49 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.69
|
$67.94M | - | 50 | Compare |
|
EDSA
Edesa Biotech, Inc. Common Shares
|
$5.35
|
$18.87M | - | 47 | Compare |
|
EVGN
EVOGENE LTD.
|
$0.52
|
$10.04M | - | 46 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.70
|
$8.39M | - | 47 | Compare |
More ENLV Analysis
Data updated: Jul 28, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry